RESUMEN
BACKGROUND AND PURPOSE: X-linked Charcot-Marie-Tooth disease type 1 (CMTX1), caused by mutations in gap junction protein beta 1 (GJB1), is characterized by various central nervous system symptoms and gender differences of clinical severity. The aim of this study was to identify the frequency and mutation spectrum of CMTX1 patients in Japan and to demonstrate their phenotypic diversities. METHODS: Using three high-throughput sequencing systems, targeted gene panel sequencing on 1483 unrelated index patients with suspected Charcot-Marie-Tooth (CMT) disease was performed. The peripheral and central nervous system involvements of all patients with GJB1 variants were assessed retrospectively and a detailed gender comparison was conducted with the CMT examination score. RESULTS: Twenty-three novel and 36 described GJB1 variants were identified from 88 pedigrees, in which 34 female and 78 male patients were enrolled. Mean age at onset of the male patients was much younger than the females, 21.56 ± 17.63 years vs. 35.53 ± 23.72 years (P = 0.007). Male patients presented with more severe phenotypes in every examination item, but statistical differences were observed only in motor dysfunctions of the lower extremities and vibration sensation. No significant sensory difference was identified between genders, either clinically or electrophysiologically. Central nervous system dysfunctions were found in 15 patients from 12 pedigrees. Therein, six patients developed stroke-like phenotypes, with dysarthria as the leading symptom. CONCLUSIONS: A relatively lower frequency of CMTX1 (5.9%) was demonstrated and a broad mutation spectrum of GJB1 was described. Detailed clinical differences between genders and various central nervous system symptoms were also illustrated, even in the same pedigree.
Asunto(s)
Enfermedad de Charcot-Marie-Tooth/diagnóstico , Conexinas/genética , Disartria/diagnóstico , Mutación , Fenotipo , Adolescente , Adulto , Edad de Inicio , Enfermedad de Charcot-Marie-Tooth/genética , Niño , Preescolar , Disartria/genética , Femenino , Humanos , Japón , Masculino , Persona de Mediana Edad , Linaje , Estudios Retrospectivos , Factores Sexuales , Adulto Joven , Proteína beta1 de Unión ComunicanteRESUMEN
BACKGROUND AND PURPOSE: The microrchidia family CW-type zinc finger 2 gene (MORC2) was newly identified as a causative gene of Charcot-Marie-Tooth disease (CMT) type 2Z in 2016. We aimed to describe the clinical and mutational spectrum of patients with CMT harboring MORC2 mutations in Japan. METHODS: We analyzed samples from 781 unrelated patients clinically diagnosed with CMT using deoxyribonucleic acid microarray or targeted resequencing by next-generation sequencing, and samples from 434 mutation-negative patients were subjected to whole-exome sequencing. We extracted MORC2 variants from these whole-exome sequencing data and classified them according to American College of Medical Genetics standards and guidelines. RESULTS: We identified MORC2 variants in 13 patients. As the second most common causative gene of CMT type 2 after MFN2, MORC2 variants were detected in 2.7% of patients with CMT type 2. The mean age of onset was 10.3 ± 8.7 years, and the inheritance pattern was mostly sporadic (11/13 patients, 84.6%). The clinical phenotype was typically length-dependent polyneuropathy, and electrophysiological studies revealed sensory-dominant axonal neuropathy. Mental retardation was identified in 4/13 patients (30.8%). p.Arg190Trp, as a mutational hotspot, was observed in eight unrelated families. We also identified two novel probably pathogenic variants, p.Cys345Tyr and p.Ala369Val, and one novel uncertain significance variant, p.Tyr332Cys. CONCLUSIONS: Our study is the largest report of patients harboring MORC2 variants. We revealed a clinical and mutational spectrum of Japanese patients with MORC2 variants. More attention should be paid to cognitive impairment, and the responsible mechanism requires further research for elucidation.
Asunto(s)
Enfermedad de Charcot-Marie-Tooth/genética , Mutación , Factores de Transcripción/genética , Adolescente , Adulto , Niño , Preescolar , Femenino , Humanos , Lactante , Japón , Masculino , Persona de Mediana Edad , Fenotipo , Adulto JovenRESUMEN
The clinical and genetic spectrum of hereditary sensory and autonomic neuropathy (HSAN) is still unknown in Japan. We collected a broad cohort of 33 unrelated patients with predominant sensory and/or autonomic dysfunctions, who were referred to our genetic laboratory. A gene panel sequencing targeting 18 HSAN-related genes was performed using a next-generation sequencing system. A recurrent frame shift mutation in the WNK1/HSN2 gene, c.3237_3238insT (p.Asp1080*), was detected in 5 patients. This mutation was homozygous in 4 cases and of a compound heterozygous genotype in 1 case. Geographic and haplotype analysis of all 5 patients suggested a founder event. In addition, a novel heterozygous nonsense variant, c.2615C>G (p.Ser872*), was identified. All the 5 patients presented with severe sensory and autonomic dysfunctions at birth or during adolescence. In 2 patients, an uncommon phenotype of acute pathological pain presented at ~50 years of age. Here, we present the first founder mutation of WNK1/HSN2, in addition to French Canadian, which accounts for ~15.2% of Japanese patients with HSAN in our cohort. We have also reviewed all previously described mutations in WNK1/HSN2 and reconciled their nomenclature strategy on the basis of the current longest transcript.
Asunto(s)
Codón sin Sentido , Efecto Fundador , Mutación del Sistema de Lectura , Neuropatías Hereditarias Sensoriales y Autónomas/genética , Proteína Quinasa Deficiente en Lisina WNK 1/genética , Adulto , Edad de Inicio , Anciano , Pueblo Asiatico , Estudios de Cohortes , Femenino , Expresión Génica , Haplotipos , Neuropatías Hereditarias Sensoriales y Autónomas/diagnóstico , Neuropatías Hereditarias Sensoriales y Autónomas/etnología , Neuropatías Hereditarias Sensoriales y Autónomas/fisiopatología , Heterocigoto , Homocigoto , Humanos , Masculino , Persona de Mediana EdadRESUMEN
BACKGROUND: Mutations in GDAP1 are responsible for heterogeneous clinical and electrophysiological phenotypes of Charcot-Marie-Tooth disease (CMT), with autosomal dominant or recessive inheritance pattern. The aim of this study is to identify the clinical and mutational spectrum of CMT patients with GDAP1 variants in Japan. MATERIALS AND METHODS: From April 2007 to October 2014, using three state-of-art technologies, we conducted gene panel sequencing in a cohort of 1,030 patients with inherited peripheral neuropathies (IPNs), and 398 mutation-negative cases were further analyzed with whole-exome sequencing. RESULTS: We identified GDAP1 variants from 10 patients clinically diagnosed with CMT. The most frequent recessive variant in our cohort (5/10), c.740C>T (p.A247V), was verified to be associated with a founder event. We also detected three novel likely pathogenic variants: c.928C>T (p.R310W) and c.546delA (p.E183Kfs*23) in Case 2 and c.376G>A (p.E126K) in Case 8. Nerve conduction study or sural nerve biopsy of all 10 patients indicated axonal type peripheral neuropathy. CONCLUSION: We identified GDAP1 variants in approximately 1% of our cohort with IPNs, and established a founder mutation in half of these patients. Our study originally described the mutational spectrum and clinical features of GDAP1-related CMT patients in Japan.
Asunto(s)
Enfermedad de Charcot-Marie-Tooth/diagnóstico , Enfermedad de Charcot-Marie-Tooth/genética , Mutación , Proteínas del Tejido Nervioso/genética , Fenotipo , Adolescente , Adulto , Alelos , Niño , Preescolar , Análisis Mutacional de ADN , Femenino , Efecto Fundador , Estudios de Asociación Genética , Genotipo , Haplotipos , Humanos , Japón , Masculino , Persona de Mediana Edad , Proteínas de la Mielina/genética , Linaje , Reproducibilidad de los Resultados , Secuenciación del Exoma , Adulto JovenRESUMEN
The anterior cruciate ligament (ACL) is divided into three fiber bundles (AM-M: anteromedial-medial, AM-L: anteromedial-lateral, PL: posterolateral). We attempted to depict the three bundles of the human ACL on MRI images and to obtain 3-dimensional visualization of them. Twenty-four knees of healthy volunteers (14 males, 10 females) were scanned by 3T-MRI using the fat suppression 3D coherent oscillatory state acquisition for the manipulation of imaging contrast (FS 3D-COSMIC). The scanned images were reconstructed after the isotropic voxel data, which allows the images to be reconstructed in any plane, was acquired. We conducted statistical examination on the identification rate of the three ACL bundles by 2D planes. Segmentation and 3D visualization of the fiber bundles using volume rendering were performed. The triple-bundle ACL was best depicted in the oblique axial plane. While the AM-M and AM-L bundles were clearly depicted in all cases, the PL bundle was not clearly visualized in two knees (8%). Therefore, the three ACL bundles were depicted in 22 knees (92%). The results of 3D visualization of the fiber arrangement agreed well with macroscopic findings of previous anatomical studies. 3T-MRI and the isotropic voxel data from FS 3D-COSMIC made it possible to demonstrate the identifiable depiction of three ACL bundles in nearly all cases. 3D visualization of the bundles could be a useful tool to understand the ACL fiber arrangement. Clin. Anat. 30:276-283, 2017. 2016 The Authors. Clinical Anatomy published by Wiley Periodicals, Inc. on behalf of American Association of Clinical Anatomists.
Asunto(s)
Ligamento Cruzado Anterior/diagnóstico por imagen , Imagen por Resonancia Magnética/métodos , Adulto , Femenino , Humanos , Imagenología Tridimensional , Masculino , Adulto JovenRESUMEN
OBJECTIVE: To identify a new genetic cause of distal hereditary motor neuropathy (dHMN), which is also known as a variant of Charcot-Marie-Tooth disease (CMT), in a Chinese family. METHODS: We investigated a Chinese family with dHMN clinically, electrophysiologically, and genetically. We screened for the mutations of 28 CMT or related pathogenic genes using an originally designed microarray resequencing DNA chip. RESULTS: Investigation of the family history revealed an autosomal dominant transmission pattern. The clinical features of the family included mild weakness and wasting of the distal muscles of the lower limb and foot deformity, without clinical sensory involvement. Electrophysiologic studies revealed motor neuropathy. MRI of the lower limbs showed accentuated fatty infiltration of the gastrocnemius and vastus lateralis muscles. All 4 affected family members had a heterozygous missense mutation c.2677G>A (p.D893N) of alanyl-tRNA synthetase (AARS), which was not found in the 4 unaffected members and control subjects. CONCLUSION: An AARS mutation caused dHMN in a Chinese family. AARS mutations result in not only a CMT phenotype but also a dHMN phenotype.
Asunto(s)
Alanina-ARNt Ligasa/genética , Enfermedad de Charcot-Marie-Tooth/enzimología , Enfermedad de Charcot-Marie-Tooth/genética , Genes Dominantes , Adolescente , Adulto , Anciano , Enfermedad de Charcot-Marie-Tooth/diagnóstico , Femenino , Tamización de Portadores Genéticos , Predisposición Genética a la Enfermedad , Humanos , Masculino , Mutación MissenseRESUMEN
OBJECTIVES: To evaluate the impact of pulmonary emphysema (PE) on the incidence and severity of radiation pneumonitis (RP) in patients with lung and mediastinal tumours. METHODS: 92 patients were enrolled. Involved-field radiation therapy (non-small cell carcinoma or mediastinal tumours in 69 patients; median 70 Gy) and accelerated hyperfractionation (limited disease small cell carcinoma in 23 patients; median 45 Gy) were performed. Common Terminology Criteria for Adverse Events v.3.0 was used to evaluate RP and the relationship with the percentage of pulmonary volume irradiated to >20 Gy (V20) and PE. PE was diagnosed by the presence of low-attenuation areas (LAAs) on CT scans and was classified into Grades 0-4 according to the extent of the LAAs. RESULTS: The median follow-up time was 16 months. The 6-month cumulative incidence of RP at Grade 3 or greater was 7.7% and 34.1% in patients with a V20 of <25% and ≥25%, respectively (p=0.017). In patients with PE Grades 0, 1, 2 and 3 or greater, the incidence of RP was 16.5%, 9.1%, 8.6% and 54.0%, respectively. As the PE Grade increased, the incidence of RP also increased significantly. CONCLUSION: The incidence and severity of RP are significantly higher in patients with a high V20 value as well as in those with severe PE.
Asunto(s)
Carcinoma de Pulmón de Células no Pequeñas/radioterapia , Neoplasias Pulmonares/radioterapia , Neoplasias del Mediastino/radioterapia , Enfisema Pulmonar/epidemiología , Neumonitis por Radiación/epidemiología , Carcinoma Pulmonar de Células Pequeñas/radioterapia , Anciano , Anciano de 80 o más Años , Carcinoma de Pulmón de Células no Pequeñas/complicaciones , Femenino , Estudios de Seguimiento , Humanos , Incidencia , Neoplasias Pulmonares/complicaciones , Masculino , Neoplasias del Mediastino/complicaciones , Persona de Mediana Edad , Enfisema Pulmonar/complicaciones , Enfisema Pulmonar/diagnóstico por imagen , Neumonitis por Radiación/clasificación , Dosificación Radioterapéutica , Estudios Retrospectivos , Factores de Riesgo , Índice de Severidad de la Enfermedad , Carcinoma Pulmonar de Células Pequeñas/complicaciones , Tomografía Computarizada por Rayos XRESUMEN
Lactobacillus brevis KB290 (KB290), a plant-derived probiotic lactic acid bacterium, improves gut health and stimulates immune function. Here we extensively investigated the teratogenicity of KB290 in rats and rabbits. We observed no adverse maternal or fetal effects and concluded that the no observable adverse effect level for maternal general toxicity, maintenance of pregnancy, and teratogenicity should be ≥ 10(10) cfu/kg/day. Our results suggest that KB290 would be safe for pregnant females and their offspring.
Asunto(s)
Levilactobacillus brevis , Exposición Materna , Probióticos , Teratógenos , Animales , Femenino , Masculino , Embarazo , Conejos , RatasRESUMEN
BACKGROUND: Schimke immuno-osseous dysplasia (SIOD) is an autosomal recessive pleiotropic disorder caused by mutations in SMARCAL1. SMARCAL1 encodes an enzyme with homology to the SNF2 chromatin remodelling proteins. METHODS: To assess the affect of SMARCAL1 mutations associated with SIOD on SMARCAL1 expression and function, we characterised the effects of various mutations on mRNA and protein expression in patient tissues and cell lines, and the ATPase activity, subcellular localisation, and chromatin binding of SMARCAL1 missense mutants. RESULTS: The SIOD associated SMARCAL1 mutations affected SMARCAL1 protein expression, stability, subcellular localisation, chromatin binding, and enzymatic activity. Further, expressing SMARCAL1 missense mutants in Drosophila melanogaster showed that disease severity was inversely proportionate to overall SMARCAL1 activity. CONCLUSION: Our results show for the first time that SMARCAL1 binds chromatin in vivo and that SIOD arises from impairment of diverse SMARCAL1 functions.
Asunto(s)
ADN Helicasas/genética , Síndromes de Inmunodeficiencia/genética , Osteocondrodisplasias/genética , Adenosina Trifosfatasas/metabolismo , Secuencia de Aminoácidos , Animales , Animales Modificados Genéticamente , Células Cultivadas , ADN Helicasas/análisis , ADN Helicasas/metabolismo , Drosophila melanogaster/genética , Drosophila melanogaster/metabolismo , Eliminación de Gen , Genes Recesivos , Humanos , Modelos Genéticos , Datos de Secuencia Molecular , Mutación , Fenotipo , ARN Mensajero/metabolismo , Alineación de SecuenciaRESUMEN
A sentinel node (SN) is defined as the first site where cancer cells are carried by lymph flow from a tumor. If this definition (SN concept) correctly reflects the clinical reality, intraoperative SN biopsy would facilitate precise nodal staging. In malignant melanoma, a prolonged survival has been evidenced by a large-scale randomized controlled study. On the contrary, research on SN concept in deeply located cancers including prostate cancer, is still investigative, and no concrete data from clinical trials are yet available. Since 1993, several investigators have demonstrated that the SN concept could be applied in prostate cancer patients as well with high accuracy. Although promising and technically feasible in pre-clinical settings, many hurdles remain to be cleared before clinical application can be recommended. This review addresses the current status and related issues of the SN concept in prostate cancer, and discusses the future directions.
RESUMEN
We report a family and a single patient in China involved with merosin-deficient congenital muscular dystrophy (MDC1A) with typical clinical symptoms. Pathological analysis of biopsied skeletal muscle showed dystrophic changes with proliferated fibrotic tissue elements as the predominant finding. Immunohistochemical analysis demonstrated the complete absence of the laminin alpha2 chain (merosin) around muscle fibers. In patient 1, a double mutation, c.[9101_9104dupAACA:3412G>A] p.[H3035QfsX4:V1138M] was detected, whereas her parents and another sibling were heterozygous carriers. Patient 2 had a novel homozygous nonsense mutation, c.2907C>A (p.Cys969X), in exon 21. The genotype-phenotype correlation of Chinese children with novel merosin-deficient congenital muscular dystrophy is reported.
Asunto(s)
Aberraciones Cromosómicas , Análisis Mutacional de ADN , Laminina/deficiencia , Laminina/genética , Distrofias Musculares/genética , Biopsia , China , Exones/genética , Femenino , Tamización de Portadores Genéticos , Homocigoto , Humanos , Lactante , Masculino , Músculo Esquelético/patología , Distrofias Musculares/diagnóstico , Distrofias Musculares/patología , Mapeo RestrictivoRESUMEN
OBJECTIVE: To determine the clinical and radiologic features of Gerstmann-Sträussler-Scheinker syndrome caused by Pro102Leu mutation in PRNP (GSS102). METHODS: The authors report 11 patients (nine families) with clinically and radiologically diagnosed GSS102. RESULTS: All patients showed mild gait disturbance, dysesthesia and hyporeflexia of the lower legs, and truncal ataxia, and 9 of 11 patients showed proximal leg muscle weakness during the early stage of the disease. Dementia was not a main symptom during the early stage. Brain MRI and EEG abnormalities were not prominent initially. SPECT (N-isopropyl-p-[(123)I]iodoamphetamine) analyzed by the three-dimensional stereotactic surface projection (SSP) method detected abnormalities in five patients early during the course of the illness. SPECT findings showed diffusely decreased cerebral blood flow, demonstrated by a mosaic pattern, with the lowest perfusion noted in the occipital lobes. In contrast, blood flow to the cerebellum was preserved. These studies suggested sites of pathology in GSS102, with the main lesions probably located in the cerebrum and the spinal cord (posterior horn and spinocerebellar tract) instead of the cerebellum. CONCLUSIONS: Key features for early diagnosis of Gerstmann-Sträussler-Scheinker syndrome caused by Pro102Leu mutation in PRNP (GSS102) are truncal ataxia, dysesthesia and hyporeflexia of the lower legs, and mild dysarthria. Normal cerebellar MRI and abnormal cerebral SPECT findings are characters of early GSS102.
Asunto(s)
Ataxia/diagnóstico , Diagnóstico por Imagen/métodos , Disartria/diagnóstico , Trastornos Neurológicos de la Marcha/diagnóstico , Enfermedad de Gerstmann-Straussler-Scheinker/diagnóstico , Hiperalgesia/diagnóstico , Amiloide/genética , Ataxia/genética , Preescolar , Diagnóstico Diferencial , Disartria/genética , Femenino , Trastornos Neurológicos de la Marcha/genética , Predisposición Genética a la Enfermedad/genética , Enfermedad de Gerstmann-Straussler-Scheinker/genética , Humanos , Hiperalgesia/genética , Lactante , Masculino , Proteínas Priónicas , Priones , Precursores de Proteínas/genética , Reflejo Anormal/genéticaRESUMEN
BACKGROUND/AIMS: A major polyphenol of green tea, epigallocatechin-3-gallate (EGCG), has previously been shown to induce cell-cycle arrest and apoptosis in various cancers. However, little is known about its effects on hepatocellular carcinomas (HCCs). METHODS: Four HCC cell lines, HLE, HepG2, HuH-7 and PLC/PRF/5, were treated with EGCG or vehicle. Cell viability was assessed by trypan blue staining and WST-8 assay. Cell-cycle, apoptosis and apoptosis-related proteins in HLE cells were evaluated by flow cytometry and Western blotting. The effect of EGCG was also studied in vivo using a xenograft model. The effect of co-treatment with EGCG and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) was also assessed. RESULTS: EGCG inhibited the growth of all HCC cell lines at concentrations of 50-100 microg/ml. In HLE cells, EGCG induced apoptosis but not cell-cycle arrest and appears to have down-regulated Bcl-2alpha and Bcl-xl by inactivation of NF-kappaB. Oral administration of EGCG showed similar effects in HLE xenograft tumors. Co-treatment with EGCG and TRAIL synergistically induced apoptosis in HLE cells. CONCLUSIONS: EGCG induced apoptosis in HLE cells, both in vitro and in vivo. Moreover, it enhanced TRAIL-induced apoptosis. Therefore, EGCG treatment may be useful for improving the prognosis of HCCs.
Asunto(s)
Anticarcinógenos/uso terapéutico , Carcinoma Hepatocelular/tratamiento farmacológico , Catequina/análogos & derivados , Neoplasias Hepáticas/tratamiento farmacológico , Proteína X Asociada a bcl-2/metabolismo , Proteína bcl-X/metabolismo , Administración Oral , Animales , Anticarcinógenos/análisis , Apoptosis , Proteínas Reguladoras de la Apoptosis/uso terapéutico , Camellia sinensis/química , Carcinoma Hepatocelular/metabolismo , Caspasas/metabolismo , Catequina/análisis , Catequina/uso terapéutico , Línea Celular Tumoral , Regulación hacia Abajo , Activación Enzimática , Humanos , Neoplasias Hepáticas/metabolismo , Masculino , Glicoproteínas de Membrana/uso terapéutico , Ratones , Ratones Endogámicos , ARN Mensajero/análisis , ARN Mensajero/metabolismo , Ligando Inductor de Apoptosis Relacionado con TNF , Té/química , Factor de Necrosis Tumoral alfa/uso terapéutico , Ensayos Antitumor por Modelo de Xenoinjerto , Proteína X Asociada a bcl-2/genética , Proteína bcl-X/genéticaRESUMEN
BACKGROUND AND AIMS: Hepatitis B virus (HBV) DNA integration into or close to cellular genes is frequently detected in HBV positive hepatocellular carcinomas (HCC). We have previously shown that viral integration can lead to aberrant target gene transcription. In this study, we attempted to investigate common pathways to hepatocarcinogenesis. METHODS: By using a modified Alu-polymerase chain reaction approach, we analysed 50 HCCs along with 10 previously published cases. RESULTS: Sixty eight cellular flanking sequences (seven repetitive or unidentified sequences, 42 cellular genes, and 19 sequences potentially coding for unknown proteins) were obtained. Fifteen cancer related genes and 25 cellular genes were identified. HBV integration recurrently targeted the human telomerase reverse transcriptase gene (three cases) and genes belonging to distinct pathways: calcium signalling related genes, 60s ribosomal protein encoding genes, and platelet derived growth factor and mixed lineage leukaemia encoding genes. Two tumour suppressor genes and five genes involved in the control of apoptosis were also found at the integration site. The viral insertion site was distributed over all chromosomes except 13, X, and Y. CONCLUSIONS: In 61/68 (89.7%) cases, HBV DNA was integrated into cellular genes potentially providing cell growth advantage. Identification of recurrent viral integration sites into genes of the same family allows recognition of common cell signalling pathways activated in hepatocarcinogenesis.
Asunto(s)
Carcinoma Hepatocelular/genética , ADN Viral/genética , Virus de la Hepatitis B/genética , Hepatitis B/genética , Neoplasias Hepáticas/genética , Integración Viral , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Señalización del Calcio/genética , Carcinoma Hepatocelular/virología , Elementos Transponibles de ADN/genética , Proteínas de Unión al ADN , Femenino , Genes Supresores de Tumor , Humanos , Leucemia/genética , Neoplasias Hepáticas/virología , Masculino , Persona de Mediana Edad , Proteínas de Neoplasias/genética , Factor de Crecimiento Derivado de Plaquetas/genética , Reacción en Cadena de la Polimerasa/métodos , Proteínas Ribosómicas/genética , Telomerasa/genética , Proteínas Virales/genéticaRESUMEN
The authors report a Japanese family segregating autosomal recessive Charcot-Marie-Tooth disease (CMT) with focally folded myelin, juvenile-onset glaucoma, and a nonsense mutation of SET binding factor 2 (SBF2). The consistent phenotypic features associated with SBF2 mutations are early-onset demyelinating neuropathy, myelin folding, and markedly decreased motor nerve conduction velocities; glaucoma associates with SBF2 nonsense mutations.
Asunto(s)
Enfermedad de Charcot-Marie-Tooth/genética , Codón sin Sentido , Glaucoma de Ángulo Abierto/genética , Proteínas Tirosina Fosfatasas/genética , Adolescente , Adulto , Edad de Inicio , Enfermedad de Charcot-Marie-Tooth/clasificación , Enfermedad de Charcot-Marie-Tooth/complicaciones , Enfermedad de Charcot-Marie-Tooth/enzimología , Enfermedad de Charcot-Marie-Tooth/epidemiología , Niño , Consanguinidad , Análisis Mutacional de ADN , Femenino , Genes Recesivos , Heterogeneidad Genética , Genotipo , Glaucoma de Ángulo Abierto/epidemiología , Glaucoma de Ángulo Abierto/etiología , Humanos , Japón/epidemiología , Masculino , Persona de Mediana Edad , Linaje , Fenotipo , Proteínas Tirosina Fosfatasas/deficiencia , Proteínas Tirosina Fosfatasas/fisiología , Proteínas Tirosina Fosfatasas no Receptoras , Procesamiento Postranscripcional del ARN , ARN Mensajero/metabolismoRESUMEN
Cytokeratin 19 fragment (CYFRA 21-1) level in serum have already been documented as a useful tumor marker for lung cancer. In the present study, we hypothesized that CYFRA 21-1 increases in the sera of patients with radiation pneumonitis, resulting from epithelial cell damage. We measured CYFRA 21-1 in the sera of patients with radiation pneumonitis and evaluated the correlation between CYFRA 21-1 level and severity of radiation pneumonitis as well as clinical course. We studied 16 patients diagnosed with radiation pneumonitis associated with primary lung cancer. CYFRA 21-1 levels in the sera of patients with diffuse radiation pneumonitis (n = 6) significantly increased compared to normal smokers (n = 10) or patients with local radiation pneumonitis (n = 10). CYFRA 21-1 values in sera changed according to the progression or improvement of the diffuse radiation pneumonitis. An immunohistochemical study using pulmonary tissues obtained from autopsied patients with radiation pneumonitis demonstrated that the hyaline membrane and proliferating type II pneumocytes were strongly stained by the anti-human cytokeratin 19 antibody. Our data demonstrated that CYFRA 21-1 was increased in patients with diffuse radiation pneumonitis. Since CYFRA 21-1 is widely used as a tumor marker for lung cancer, this evidence should be noted especially in irradiated patients.
Asunto(s)
Antígenos de Neoplasias/sangre , Células Epiteliales/efectos de la radiación , Neumonitis por Radiación/diagnóstico , Anciano , Anciano de 80 o más Años , Biomarcadores/sangre , Femenino , Humanos , Inmunohistoquímica , Queratina-19 , Queratinas , Neoplasias Pulmonares/radioterapia , Masculino , Persona de Mediana Edad , Resultado del TratamientoRESUMEN
The OH radical scavenging activity of a series of Gd(III) MRI contrast media, such as Gd(III)DTPA, Gd(III)BMA and Gd(III)DO3A, were evaluated by means of EPR spin trapping measurements. The second order reaction rate constant (k2) occurring between Gd(III)DTPA and OH radical was estimated to be 3.26 x 10(10) (M(-1)s(-1)), which was ten times larger than that of the free ligand DTPA (3.86 x 10(9) M(-1)s(-1). The k2 values of Gd(III)BMA and Gd(III)DO3A were also determined to be 1.31 x 10(10) and 1.77 x 10(10) (M(-1)s(1)), respectively. The present results suggest that widely used Gd(III) containing MRI reagent exhibit OH radical scavenging activity, and these values of k2 are same order as that of ascorbic acid (1.16 x 10(10) M(-1)s(-1)) which has been well established to be the most powerful OH radical scavenger. Based on the EPR measurements performed for these Gd(III) complexes, a possible reaction mechanism of the OH radical scavenging action of these MRI contrast media will be discussed.
Asunto(s)
Medios de Contraste/química , Gadolinio DTPA/química , Radical Hidroxilo/química , Imagen por Resonancia Magnética/métodos , Quelantes/química , Óxidos N-Cíclicos/química , Espectroscopía de Resonancia por Spin del Electrón , Gadolinio , Compuestos Heterocíclicos/química , Peróxido de Hidrógeno/química , Compuestos Organometálicos/química , Detección de SpinRESUMEN
Neurofilament light chain polypeptide (NEFL) is one of the most abundant cytoskeletal components of the neuron. Mutations in the NEFL gene were recently reported as a cause for autosomal dominant Charcot-Marie-Tooth type 2E (CMT2E) linked to chromosome 8p21. In order to investigate the frequency and phenotypic consequences of NEFL mutations, we screened 323 patients with CMT or related peripheral neuropathies. We detected six disease associated missense mutations and one 3-bp in-frame deletion clustered in functionally defined domains of the NEFL protein. Patients have an early onset and often a severe clinical phenotype. Electrophysiological examination shows moderately to severely slowed nerve conduction velocities. We report the first nerve biopsy of a CMT patient with a de novo missense mutation in NEFL, and found an axonal pathology with axonal regeneration clusters and onion bulb formations. Our findings provide further evidence that the clinical variation observed in CMT depends on the gene mutated and the specific type of mutation, and we also suggest that NEFL mutations need to be considered in the molecular evaluation of patients with sporadic or dominantly inherited CMT.
Asunto(s)
Enfermedad de Charcot-Marie-Tooth/genética , Mutación , Proteínas de Neurofilamentos/genética , Adolescente , Axones/patología , Enfermedad de Charcot-Marie-Tooth/patología , Enfermedad de Charcot-Marie-Tooth/fisiopatología , Niño , Preescolar , Electrofisiología , Eliminación de Gen , Humanos , Lactante , Microscopía Electrónica , Mutación Missense , Nervio Sural/patologíaRESUMEN
OBJECTIVES: To clarify the clinical variability, including central nervous system (CNS) involvement, in X-linked Charcot-Marie-Tooth disease (CMTX) patients. MATERIAL AND METHODS: We clinically, pathologically and genetically studied six CMTX patients with distinct symptoms and four different GJB1 mutations. RESULTS: One patient with Val63Ile had deafness, low intelligence, saccadic eye movement, upper extremity distal dominant muscle weakness and normal sensation. Another patient with Glu186Lys had severe sensorineural deafness at the age of 6 years, but did not develop muscle weakness until the age of 20 years. Two patients with Arg22Gln had typical CMT1A-like clinical features, no CNS symptoms and obvious onion bulb formations. Two siblings with deletion of the entire GJB1 gene had mild to moderate lower extremity muscle weakness and sensory disturbance without CNS involvement. CONCLUSION: These findings suggest that some gain of function mutations of GJB1 may be related to CNS symptoms because the patients with GJB1 deletion only had peripheral neuropathy, although other unknown associated factors may contribute to their clinical phenotypes.